DMAC
Price
$6.14
Change
+$0.77 (+14.34%)
Updated
Sep 5 closing price
Capitalization
317.37M
60 days until earnings call
HLOSF
Price
$4.11
Change
-$0.34 (-7.64%)
Updated
Aug 18 closing price
Capitalization
423.46M
Interact to see
Advertisement

DMAC vs HLOSF

Header iconDMAC vs HLOSF Comparison
Open Charts DMAC vs HLOSFBanner chart's image
DiaMedica Therapeutics
Price$6.14
Change+$0.77 (+14.34%)
Volume$754.56K
Capitalization317.37M
HEALIOS K K
Price$4.11
Change-$0.34 (-7.64%)
Volume$249
Capitalization423.46M
DMAC vs HLOSF Comparison Chart in %
Loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DMAC vs. HLOSF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a Hold and HLOSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DMAC: $6.14 vs. HLOSF: $4.11)
Brand notoriety: DMAC and HLOSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 208% vs. HLOSF: 29%
Market capitalization -- DMAC: $317.37M vs. HLOSF: $423.46M
DMAC [@Biotechnology] is valued at $317.37M. HLOSF’s [@Biotechnology] market capitalization is $423.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whileHLOSF’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • HLOSF’s FA Score: 0 green, 5 red.
According to our system of comparison, both DMAC and HLOSF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 5 TA indicator(s) are bullish while HLOSF’s TA Score has 3 bullish TA indicator(s).

  • DMAC’s TA Score: 5 bullish, 3 bearish.
  • HLOSF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, DMAC is a better buy in the short-term than HLOSF.

Price Growth

DMAC (@Biotechnology) experienced а +7.53% price change this week, while HLOSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

DMAC is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($423M) has a higher market cap than DMAC($317M). HLOSF YTD gains are higher at: 204.444 vs. DMAC (13.076). DMAC has higher annual earnings (EBITDA): -31.42M vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 6.25B vs. DMAC (30M). DMAC has less debt than HLOSF: DMAC (292K) vs HLOSF (2.61B). HLOSF has higher revenues than DMAC: HLOSF (112M) vs DMAC (0).
DMACHLOSFDMAC / HLOSF
Capitalization317M423M75%
EBITDA-31.42M-2.39B1%
Gain YTD13.076204.4446%
P/E RatioN/AN/A-
Revenue0112M-
Total Cash30M6.25B0%
Total Debt292K2.61B0%
FUNDAMENTALS RATINGS
DMAC: Fundamental Ratings
DMAC
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DMACHLOSF
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
20%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
29%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
27%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
15%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
12%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPNGY26.300.42
+1.60%
MEITUAN
BCUCF111.00N/A
N/A
Brunello Cucinelli S P A
TKCBF5.99N/A
N/A
Tokai Carbon Company Ltd.
QQFSF0.06N/A
N/A
Qinqin Foodstuffs Group Cayman Co Ltd
LPSIF0.08N/A
N/A
Legend Power Systems Inc.

DMAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with WHWK. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then WHWK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
+14.34%
WHWK - DMAC
47%
Loosely correlated
+0.55%
ARCT - DMAC
38%
Loosely correlated
+6.50%
HUMA - DMAC
36%
Loosely correlated
-2.05%
VICP - DMAC
33%
Poorly correlated
N/A
LQDA - DMAC
32%
Poorly correlated
+0.03%
More

HLOSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLOSF has been loosely correlated with ORKA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if HLOSF jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
ORKA - HLOSF
62%
Loosely correlated
-3.04%
PCVX - HLOSF
39%
Loosely correlated
+0.16%
CYYNF - HLOSF
39%
Loosely correlated
N/A
FHTX - HLOSF
23%
Poorly correlated
+2.28%
DMAC - HLOSF
22%
Poorly correlated
+1.32%
More